Alpha Tau Medical Earnings Date & Estimates

Alpha Tau Medical (NASDAQ:DRTSW) is a clinical-stage medical technology company developing radiation-based treatments for solid tumors. Its lead platform, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), is designed to deliver highly potent alpha radiation directly within a tumor while limiting exposure to surrounding healthy tissue.

The Alpha DaRT system uses implanted sources containing radium-224. As the material decays, it generates radioactive atoms that diffuse through the tumor and release alpha particles, which can damage cancer cells. The company has evaluated the technology in clinical studies involving several types of solid tumors and continues to pursue regulatory approvals and expanded clinical applications.

Founded in Israel, Alpha Tau has conducted research and clinical development activities in Israel and other international markets, including the United States and Europe. The company is led by co-founder and Chief Executive Officer Uzi Sofer, who has overseen the development and advancement of its alpha-radiation treatment platform.